Modern Cancer Management Practices: A Complete Patient and Family Guide

At a glance: Modern cancer management is not one medicine, procedure or philosophy. It is a coordinated system of care that combines scientifically validated cancer treatments with symptom management, rehabilitation, nutrition, emotional support, palliative care, carefully selected integrative practices and long-term follow-up.

The central goal is personalized, evidence-based, whole-person care: treating the cancer as effectively as possible while protecting safety, function, dignity, informed choice and quality of life.

Important distinction: Supportive and integrative therapies may help manage symptoms and treatment effects, but they do not replace medically indicated surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, hormone therapy, stem cell transplant or another cancer-directed treatment.

Safety message: Cancer treatment decisions should be made using a confirmed diagnosis, reliable staging, appropriate pathology and biomarker information, realistic goals, expected benefits, possible harms and the patient’s values.

Do not delay urgent evaluation or replace recommended treatment with unproven alternatives, online protocols, secret remedies or commercial cure claims.

Quick Jump: Modern Cancer Management Topics

• What Is Modern Cancer Management?
• Core Principles
• The Cancer-Care Continuum
• Accurate Diagnosis
• Pathology and Tumor Classification
• Stage, Grade and Risk
• Biomarker and Molecular Testing
• Inherited Genetic Testing
• Multidisciplinary Care Team
• Tumor Boards
• Goals of Treatment
• Shared Decision-Making
• Second Opinions
• Creating the Treatment Plan
• Surgery
• Radiation Therapy
• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Hormone Therapy
• Stem Cell Transplant
• Cellular and Advanced Therapies
• Other Local Treatments
• Multimodal Treatment
• Treatment Sequencing
• Precision Oncology
• Clinical Trials
• Supportive Care
• Palliative Care
• Hospice Care
• Integrative Medicine
• Alternative-Therapy Safety
• Symptom Management
• Rehabilitation and Prehabilitation
• Exercise and Physical Activity
• Nutrition Care
• Mental and Emotional Health
• Fertility and Sexual Health
• Caregiver Support
• Monitoring Treatment
• Measuring Treatment Response
• Resistance and Recurrence
• Managing Side Effects
• Medication Safety
• Infection Prevention
• Urgent Warning Signs
• Telehealth and Digital Care
• Artificial Intelligence in Cancer Care
• Patient Navigation
• Equity and Access
• Financial Toxicity
• Children, Teens and Young Adults
• Older Adults
• Survivorship Care
• Advanced Cancer Management
• Quality and Safety
• Questions to Ask
• Myths and Facts
• Management Checklist
• Trusted Resources

Modern cancer management is the organized process of diagnosing, classifying, treating, monitoring and supporting a person affected by cancer.

It brings together:

• Accurate pathology and imaging
• Cancer staging and risk assessment
• Biomarker and genetic testing when appropriate
• Multidisciplinary specialist review
• Evidence-based local and systemic treatments
• Clinical trials
• Supportive and palliative care
• Rehabilitation, nutrition and mental-health care
• Evidence-informed integrative practices
• Response and toxicity monitoring
• Survivorship and long-term follow-up
• Care for recurrent or advanced disease
• Patient values, goals and preferences

The treatment plan is not static. It may change when new test results become available, treatment causes unacceptable toxicity, the cancer responds, the cancer progresses or the patient’s goals change.

1. Confirm the diagnosis before treating.
2. Define the cancer’s extent and biology.
3. Set a clear treatment goal.
4. Use treatments supported by reliable evidence.
5. Personalize care to the patient and cancer.
6. Combine treatment methods when this improves outcomes.
7. Prevent and treat side effects early.
8. Include the patient in major decisions.
9. Coordinate care across specialties and settings.
10. Reassess benefits and harms throughout treatment.
11. Address physical, emotional, social and spiritual needs.
12. Plan for survivorship from the time of diagnosis.
13. Protect patients from misinformation and unproven alternatives.
14. Provide equitable access regardless of background or location.

Cancer care may include several overlapping phases:

1. Prevention and risk reduction
2. Screening and early detection
3. Evaluation of symptoms or abnormal findings
4. Diagnosis and pathology confirmation
5. Staging and risk classification
6. Treatment planning
7. Active cancer-directed treatment
8. Supportive and palliative care
9. Response assessment
10. Maintenance or ongoing treatment
11. Surveillance and survivorship
12. Management of recurrence or progression
13. Advanced-care planning and end-of-life support when needed

Treatment should be based on a clearly established diagnosis. Evaluation may include:

• Medical history and physical examination
• Blood and urine testing
• X-ray, ultrasound, CT, MRI, PET or nuclear imaging
• Endoscopy
• Biopsy or surgical tissue sampling
• Bone-marrow examination
• Cytology
• Pathology review
• Immunohistochemistry
• Flow cytometry
• Cytogenetic or molecular testing

A suspicious scan alone may not identify the exact cancer type. Whenever medically appropriate, tissue or another reliable diagnostic specimen should establish what disease is being treated.

Urgent situations may require treatment before every result is complete, but the team should obtain the most reliable diagnosis possible without creating unsafe delay.

The pathology report may identify:

• The tissue or organ of origin
• The cancer type and subtype
• Cell appearance and differentiation
• Tumor grade
• Margins after surgery
• Lymph-node involvement
• Hormone-receptor status
• Protein or molecular markers
• Lymphovascular or perineural invasion
• Features associated with prognosis or treatment response

Pathology terminology can be complex. Patients may request a plain-language explanation and a copy of the report.

A pathology second opinion may be valuable for rare cancers, unusual findings, major treatment decisions or disagreement between clinical and laboratory information.

Stage

Stage describes how much cancer is present and whether it has spread. Staging systems differ among cancer types.

Grade

Grade generally describes how abnormal the cancer cells look and may help estimate how aggressively the cancer could behave.

Risk Group

Risk classification may combine stage, grade, age, blood tests, molecular findings, tumor size and other disease-specific factors.

Prognosis

Prognosis is an estimate based on groups of patients. It cannot predict exactly what will happen to one individual. Modern treatment and individual biology may produce outcomes different from historical statistics.

Biomarker testing examines genes, proteins or other characteristics of cancer that may help with diagnosis, prognosis, treatment selection or clinical-trial matching.

Testing may use:

• Tumor tissue
• Blood or another body fluid
• Immunohistochemistry
• Fluorescence or other in situ hybridization
• PCR-based testing
• DNA or RNA sequencing
• Next-generation sequencing panels
• Protein-expression testing
• Liquid-biopsy methods

Results may identify:

• A treatment-linked biomarker
• A resistance marker
• A prognostic finding
• A clinical-trial opportunity
• A variant of uncertain significance
• No currently actionable alteration
• An inadequate or inconclusive sample

Not every cancer requires broad molecular testing, and not every detected change has an effective treatment.

National Cancer Institute: Biomarker Testing for Cancer Treatment

Tumor biomarker testing is different from testing for inherited genetic changes present throughout the body.

Inherited testing may be considered when there is:

• Cancer at an unusually young age
• Several relatives with related cancers
• Multiple primary cancers in one person
• A cancer type associated with hereditary syndromes
• A tumor result suggesting a possible inherited change
• Ancestry or family history associated with a known variant

Results may influence treatment, screening for new cancers, risk-reducing decisions and relatives’ care.

Genetic counseling can help patients understand testing choices, uncertain findings, privacy concerns and possible family implications.

Modern cancer management frequently involves several professionals, including:

• Medical oncologists and hematologists
• Surgical oncologists and specialty surgeons
• Radiation oncologists
• Pathologists
• Radiologists and nuclear-medicine physicians
• Interventional radiologists
• Oncology nurses and advanced-practice clinicians
• Pharmacists
• Genetic counselors
• Palliative-care specialists
• Registered dietitians
• Physical and occupational therapists
• Speech and swallowing therapists
• Psychologists, psychiatrists and counselors
• Social workers and patient navigators
• Fertility and sexual-health specialists
• Primary-care professionals
• Chaplains and spiritual-care professionals

A tumor board is a meeting in which specialists review a patient’s diagnosis, imaging, pathology, stage and treatment options.

Tumor-board review may be especially useful for:

• Rare or complex cancers
• Uncertain diagnosis
• Borderline surgical cases
• Multiple possible treatment sequences
• Recurrence after several treatments
• Complex biomarker findings
• Clinical-trial consideration

A tumor-board recommendation supports—but does not replace—a direct conversation with the patient about choices and preferences.

Cure

Treatment aims to eliminate the cancer and prevent it from returning.

Long-Term Control

Treatment aims to suppress cancer, delay progression and support meaningful life over time.

Reducing Recurrence Risk

Treatment is given after initial local therapy to eliminate microscopic disease.

Making Local Treatment Possible

Treatment may shrink cancer before surgery or radiation.

Symptom Relief

Treatment may relieve pain, bleeding, blockage, pressure or other symptoms even when cure is not expected.

Preserving Function and Quality of Life

A plan may prioritize independence, cognition, mobility, communication, fertility or another patient-defined goal.

Shared decision-making is a process in which patients and health professionals work together to select a plan.

The discussion should include:

• The diagnosis and treatment goal
• Available options
• Expected benefits
• Major risks and uncertainties
• Effects on daily life
• Alternatives, including observation when appropriate
• The patient’s values, concerns and priorities
• Costs and practical barriers

Patients may ask for plain language, an interpreter, written information, decision aids and additional time when medically safe.

National Cancer Institute: Shared Decision-Making

A second opinion may:

• Confirm the diagnosis
• Clarify stage or pathology
• Provide another surgical or radiation approach
• Identify biomarker testing
• Suggest a clinical trial
• Explain risks differently
• Confirm that the original plan is appropriate

Second opinions are particularly valuable for rare cancer, major surgery, organ-removing treatment, uncertain pathology, unusual molecular findings and decisions with several reasonable options.

Urgent cancers should not be dangerously delayed. The original team can explain how quickly treatment must begin.

The plan may consider:

• Cancer type, subtype, stage and grade
• Biomarkers and inherited findings
• Prior treatment
• Age and overall health
• Heart, lung, liver and kidney function
• Pregnancy and fertility goals
• Functional status and frailty
• Other medical conditions
• Medication interactions
• Patient goals and preferences
• Clinical-trial availability
• Transportation, insurance and caregiver support

Surgery may be used to:

• Diagnose cancer
• Remove the primary tumor
• Assess lymph nodes
• Reduce tumor burden
• Prevent complications
• Relieve blockage, bleeding or pressure
• Reconstruct an affected body area

Modern surgery may use open, minimally invasive, robotic, image-guided, organ-preserving or reconstructive techniques.

The best operation is not always the largest operation. Cancer control, surgical safety, function, appearance, recovery and quality of life should all be considered.

Radiation therapy uses carefully planned high-energy treatment to damage cancer cells while limiting exposure to healthy tissues.

It may be used:

• As the main curative treatment
• Before surgery
• After surgery
• With chemotherapy or systemic therapy
• To control a limited number of metastases
• To relieve pain, bleeding, obstruction or neurologic symptoms

Techniques may include external-beam radiation, stereotactic treatment, brachytherapy, proton therapy and radiopharmaceutical approaches in selected situations.

Chemotherapy uses medicines that kill or stop the growth of rapidly dividing cells.

It may be given:

• Before local treatment
• After surgery
• At the same time as radiation
• As the main treatment for blood cancers
• To control recurrent or metastatic disease
• To reduce symptoms

Modern chemotherapy management includes individualized dosing, prevention of nausea, infection monitoring, organ-function testing, growth-factor support, dose adjustments and symptom-directed care.

Targeted therapy acts on molecular changes or proteins that help cancer grow, divide, survive or spread.

Examples include:

• Small-molecule inhibitors
• Monoclonal antibodies
• Antibody-drug conjugates
• Angiogenesis inhibitors
• DNA-repair inhibitors
• Cell-cycle inhibitors
• Tumor-agnostic treatments for selected biomarkers

Testing may be necessary to confirm that the target is present. Cancer can also develop resistance, requiring repeat testing or a new treatment strategy.

Immunotherapy helps the immune system identify, attack or control cancer.

Approaches include:

• Immune-checkpoint inhibitors
• Monoclonal and bispecific antibodies
• Cancer vaccines
• Cytokine therapies
• Cellular therapies

Immunotherapy may produce durable benefit in selected patients, but not every cancer responds.

Immune-related side effects can inflame healthy organs and may require urgent treatment.

Some breast, prostate, endometrial and other cancers depend on hormonal signaling.

Hormone therapy may:

• Lower hormone production
• Block hormone receptors
• Destroy or degrade a receptor
• Suppress ovarian or testicular function

Treatment may continue for months or years and requires attention to bone health, cardiovascular risk, metabolism, fertility, sexual health, hot flashes and medication adherence.

Stem cell transplantation restores or replaces blood-forming stem cells after intensive therapy.

The transplant may use:

• The patient’s own cells
• Cells from a matched or partially matched donor
• Bone marrow
• Peripheral blood stem cells
• Umbilical cord blood

Transplantation requires specialized infection prevention, donor selection, conditioning, engraftment monitoring and long-term follow-up.

Modern oncology increasingly uses therapies made from or directed through living immune cells.

Examples include:

• CAR T-cell therapy
• Tumor-infiltrating lymphocyte therapy
• T-cell receptor therapies
• Donor lymphocyte infusion
• Experimental natural-killer-cell and gene-modified approaches

These treatments are not interchangeable. They have disease-specific indications and may cause serious inflammatory, neurologic, blood-count or infection complications.

Selected tumors may be treated using local or regional procedures such as:

• Radiofrequency or microwave ablation
• Cryoablation
• Laser treatment
• Photodynamic therapy
• Embolization or chemoembolization
• Radioembolization
• Focused ultrasound
• Medical hyperthermia
• Intracavitary or regional drug delivery

Many cancers are treated with more than one method because different treatments address different disease risks.

Examples include:

• Surgery followed by chemotherapy
• Surgery followed by radiation
• Chemotherapy and radiation given together
• Systemic treatment before surgery
• Targeted therapy combined with chemotherapy
• Immunotherapy combined with chemotherapy
• Hormone therapy combined with targeted therapy
• Radiation used to control selected metastases during systemic treatment

Combining treatments can improve cancer control, but it may also increase toxicity. The expected benefit should justify the additional burden.

Neoadjuvant Therapy

Treatment given before the main local treatment to shrink cancer, test treatment sensitivity or improve surgical options.

Adjuvant Therapy

Treatment given after surgery or another primary treatment to reduce recurrence risk.

Concurrent Therapy

Two treatments are given during the same period, such as chemotherapy with radiation.

Induction Therapy

The first intensive treatment used to achieve remission or major disease reduction.

Consolidation Therapy

Additional treatment given after response to strengthen disease control.

Maintenance Therapy

Ongoing, often less intensive treatment used to prolong control or reduce relapse risk.

Precision oncology uses information about the cancer and patient to select care more specifically.

Precision may involve:

• Molecularly targeted treatment
• Biomarker-selected immunotherapy
• Pharmacogenomic information
• Risk-adapted treatment intensity
• Radiation planning based on anatomy and motion
• Image-guided surgery
• Measurable-residual-disease assessment
• Patient-specific toxicity monitoring

Precision medicine does not guarantee that a matching treatment exists or will work.

The best plan may still include established surgery, chemotherapy or radiation even when molecular testing has been performed.

Clinical trials evaluate new treatments, combinations, sequencing methods, supportive interventions, diagnostic tools and strategies for preventing recurrence.

Trial participation may be considered:

• At initial diagnosis
• Before surgery
• After standard treatment
• For rare cancer
• For recurrent or resistant cancer
• For symptom-management research

A clinical trial is not automatically better than standard care and cannot guarantee benefit. Patients should understand the study phase, purpose, alternatives, extra procedures, possible costs and unknown risks.

National Cancer Institute: Find Cancer Clinical Trials

Supportive care prevents or treats symptoms and side effects as early as possible.

It may include:

• Pain management
• Anti-nausea treatment
• Infection prevention
• Blood-count support
• Nutrition care
• Management of fatigue
• Mouth and skin care
• Rehabilitation
• Mental-health support
• Fertility preservation
• Sexual-health care
• Social and financial support
• Spiritual care

Supportive care should begin when a need is identified—not only after symptoms become severe.

Palliative care is specialized whole-person care focused on quality of life for people with serious illness.

It may address:

• Pain
• Breathlessness
• Nausea and appetite loss
• Fatigue and sleep
• Anxiety and depression
• Communication and treatment goals
• Family and caregiver needs
• Spiritual concerns
• Financial and practical problems

Palliative care can be provided at any age or disease stage and can occur alongside treatment intended to cure or control cancer.

National Cancer Institute: Palliative Care in Cancer

Hospice is a form of care used when cure or disease-directed control is no longer the central goal and care focuses on comfort, dignity and quality of life.

Hospice may provide:

• Pain and symptom management
• Nursing care
• Medical equipment and medicines related to comfort
• Emotional and spiritual support
• Caregiver education
• Bereavement support

Palliative care and hospice are not the same. Palliative care can begin much earlier and may accompany active cancer treatment.

Integrative oncology combines standard cancer care with selected complementary practices that have an acceptable safety profile and may support symptom management or well-being.

Approaches may include:

• Acupuncture
• Mindfulness and meditation
• Yoga, tai chi or qigong
• Relaxation and guided imagery
• Oncology massage
• Music and art therapy
• Spiritual care
• Evidence-informed nutrition support

Practices should be adapted for blood counts, bone health, surgery, radiation skin changes, ports, lymphedema, immune suppression and other individual risks.

NCCIH: Cancer and Complementary Health Approaches

Alternative therapy is an unproven method used instead of appropriate medical care.

High-risk examples include:

• Replacing surgery with an extreme diet
• Replacing chemotherapy with herbs
• Using unapproved infusions instead of radiation
• Delaying treatment for detoxification
• Relying on energy healing to remove a tumor
• Using veterinary or unapproved drugs without medical supervision

No complementary health approach has been shown to cure cancer. Unproven products should not replace or delay effective care.

Symptoms should be assessed according to cause rather than treated automatically with one approach.

Commonly addressed concerns include:

• Pain
• Nausea and vomiting
• Fatigue
• Diarrhea or constipation
• Shortness of breath
• Neuropathy
• Mouth sores
• Skin reactions
• Loss of appetite
• Weight and muscle loss
• Sleep disturbance
• Hot flashes
• Cognitive changes
• Anxiety and depression

Prehabilitation begins before treatment and aims to improve physical, nutritional or emotional readiness.

Rehabilitation helps patients recover or adapt during and after treatment.

Services may address:

• Weakness and loss of endurance
• Balance and fall risk
• Neuropathy
• Lymphedema
• Swallowing and speech
• Pelvic-floor function
• Daily activities
• Cognitive concerns
• Return to work or school

Appropriately selected physical activity may support strength, function, fatigue management, mood, balance and cardiovascular health.

A plan may include:

• Walking or aerobic activity
• Resistance exercise
• Balance training
• Flexibility work
• Breathing exercises
• Condition-specific rehabilitation

Supervision may be needed for bone metastases, severe anemia, low platelets, neuropathy, infection, heart or lung limitations, recent surgery or major fall risk.

Nutrition goals may include maintaining weight, preserving muscle, supporting healing, managing digestive symptoms and improving treatment tolerance.

Nutrition support may address:

• Loss of appetite
• Taste and smell changes
• Mouth sores or dry mouth
• Difficulty swallowing
• Nausea, diarrhea or constipation
• Unplanned weight loss
• Diabetes or organ disease
• Tube feeding or intravenous nutrition
• Food interactions with oral medicines

The best diet during active treatment may differ from a long-term cancer-prevention diet. Severe restriction may worsen malnutrition.

Cancer can affect mood, sleep, identity, relationships, employment, parenting, school and financial stability.

Support may include:

• Individual or family counseling
• Psychiatric care
• Support groups
• Peer mentoring
• Mindfulness-based programs
• Medication when appropriate
• Social-work services
• Spiritual care

Emotional distress is not a personal failure. Persistent anxiety, depression, panic, confusion or inability to function deserves professional evaluation.

Cancer and treatment may affect fertility, hormones, pregnancy safety, sexual function and body image.

Before treatment, patients may discuss:

• Sperm banking
• Egg or embryo freezing
• Ovarian-tissue preservation in selected cases
• Radiation protection or surgical planning
• Contraception requirements
• Timing of future pregnancy

Sexual-health concerns may include pain, dryness, narrowing, erectile changes, loss of desire, infertility and relationship strain. These concerns are legitimate parts of cancer care.

Caregivers may help with:

• Transportation
• Medication schedules
• Symptom monitoring
• Communication
• Meals and household tasks
• Emotional support
• Insurance and finances
• Emergency response

Caregivers may also experience exhaustion, disrupted sleep, anxiety, financial stress and health problems.

A modern care plan should identify caregiver needs, backup support and respite options.

Monitoring may include:

• Physical examinations
• Blood counts and chemistry tests
• Liver, kidney, heart or lung assessment
• Imaging
• Tumor markers
• Bone-marrow examinations
• Molecular or residual-disease testing
• Patient-reported symptoms
• Medication adherence
• Weight and functional status

Monitoring should detect benefit, toxicity and disease progression early enough to guide decisions.

Response may be described as:

• Complete response
• Partial response
• Stable disease
• Progressive disease
• Pathologic response after surgery
• Hematologic, molecular or measurable-residual-disease response

The method depends on the cancer. A lower tumor marker alone may not prove response, and symptom improvement does not always mean the cancer is shrinking.

Some treatments can temporarily produce imaging or inflammatory patterns that require specialist interpretation.

Cancer may resist treatment from the beginning or develop resistance over time.

When cancer progresses, the team may consider:

• Confirming progression
• Repeating biopsy or molecular testing
• Changing systemic therapy
• Adding local treatment
• Using a different treatment mechanism
• Clinical-trial enrollment
• Strengthening supportive and palliative care

A treatment change is not necessarily a failure of care. It may reflect the evolving biology of cancer.

Side-effect management may include:

• Preventive medicines
• Dose interruption or reduction
• Changing treatment
• Growth factors or transfusions
• Hydration and electrolyte replacement
• Antibiotics or antiviral therapy
• Corticosteroids or immune-suppressing treatment
• Rehabilitation and nutrition support
• Hospitalization when needed

A dose reduction does not automatically mean that treatment is ineffective. Adjustments may preserve safety and allow treatment to continue.

Patients should maintain an updated list of:

• Prescription medicines
• Nonprescription medicines
• Vitamins and minerals
• Herbs and supplements
• Allergies and previous reactions

For oral cancer therapy, ask about:

• Food and fasting requirements
• Missed doses
• Vomiting after a dose
• Crushing or splitting tablets
• Storage and handling
• Drug and supplement interactions
• Safe disposal

Never double a dose, stop treatment or change the schedule without instructions from the prescribing team.

Cancer and treatment may weaken immune defenses.

Prevention may include:

• Hand hygiene
• Central-line care
• Food safety
• Preventive medicines
• Avoiding close contact with contagious illness
• Vaccination according to oncology guidance
• Prompt fever evaluation

Vaccine timing depends on treatment type, immune recovery and whether the vaccine contains a live organism. Patients should check with the cancer team before vaccination.

Follow the cancer center’s written emergency instructions. Contact the team promptly for:

• Fever at or above the center’s threshold
• Shaking chills
• New or worsening breathing difficulty
• Chest pain or fainting
• Confusion, seizure or severe headache
• New weakness, numbness or speech changes
• Uncontrolled bleeding
• Severe vomiting or inability to drink
• Severe or rapidly worsening diarrhea
• Very little urine
• Yellow skin or eyes
• Rapidly spreading rash, blistering or peeling skin
• Facial, tongue or throat swelling
• Severe abdominal or back pain
• Possible treatment or supplement overdose
• Any symptom identified as urgent by the oncology team

Seek emergency medical care for severe breathing problems, signs of stroke, loss of consciousness, seizure, uncontrolled bleeding, severe chest pain or another immediately life-threatening condition.

Digital tools may support:

• Telehealth visits
• Symptom reporting
• Medication reminders
• Home blood pressure or weight monitoring
• Access to records and results
• Patient education
• Care coordination
• Remote palliative or mental-health care

Digital care does not replace physical examination, emergency evaluation, laboratory testing or imaging when these are medically required.

Patients should know who reviews submitted symptoms and how quickly to expect a response.

Artificial intelligence may assist with:

• Medical-image analysis
• Pathology review
• Radiation planning
• Clinical-trial matching
• Risk prediction
• Documentation and care coordination
• Patient education

AI tools can make errors, reproduce bias, misunderstand context or provide outdated information.

AI should support—not replace—qualified clinical judgment, informed consent, pathology confirmation and direct patient care.

Patient navigation helps identify and reduce barriers to timely care.

Navigation may assist with:

• Scheduling
• Referrals
• Transportation
• Insurance
• Clinical trials
• Language access
• Health education
• Housing and food needs
• Communication among specialists

President’s Cancer Panel: Patient Navigation and Equity

High-quality care should not depend on race, ethnicity, language, income, disability, rural location, age, sex, gender identity or insurance status.

Equitable care may require:

• Professional interpreters
• Accessible facilities and information
• Transportation and lodging support
• Telehealth options
• Culturally respectful communication
• Clinical-trial access
• Financial navigation
• Coordination with community resources

Financial toxicity describes the harmful financial effects of cancer and treatment.

Costs may include:

• Insurance deductibles and copayments
• Medicines
• Travel, parking and lodging
• Child care
• Lost income
• Caregiver leave
• Medical equipment
• Fertility preservation
• Long-term rehabilitation

Patients should be offered financial counseling, insurance assistance and lower-cost treatment alternatives when medically appropriate.

Pediatric and young-adult care must consider:

• Growth and development
• Puberty and fertility
• School participation
• Family-centered decision-making
• Age-appropriate communication
• Long-term heart, lung, bone and hormone health
• Transition to adult care
• Decades of survivorship follow-up

Children and teens should be treated in settings with appropriate pediatric or adolescent and young-adult expertise whenever possible.

Calendar age alone should not determine treatment.

Assessment may include:

• Functional independence
• Frailty
• Cognition
• Nutrition
• Falls
• Medication burden
• Social support
• Other illnesses
• Life expectancy and treatment goals

Some older adults can safely receive intensive treatment. Others benefit from adjusted dosing, less invasive treatment or a stronger focus on function and quality of life.

Survivorship begins at diagnosis and continues throughout life.

After active treatment, care may include:

• Monitoring for recurrence
• Screening for new cancers
• Managing long-term and late effects
• Rehabilitation
• Heart, lung, bone and hormone monitoring
• Mental-health support
• Sexual-health and fertility care
• Return-to-work or school planning
• Routine primary care and prevention

Patients should receive a treatment summary and follow-up care plan that identifies treatments received, possible late effects, surveillance needs and which clinicians are responsible for follow-up.

National Cancer Institute: Follow-Up Medical Care

Advanced cancer care may involve several changing goals:

• Controlling disease
• Extending life
• Relieving symptoms
• Preserving independence
• Maintaining time at home
• Avoiding burdensome treatment
• Planning for future care

Treatment decisions should consider how likely a therapy is to help, how soon benefit may occur, possible toxicity and what matters most to the patient.

Advance-care planning does not remove hope. It helps ensure that future care reflects the patient’s values.

High-quality cancer care should provide:

• Timely diagnosis and treatment
• Accurate pathology and staging
• Evidence-based recommendations
• Clear informed consent
• Medication and radiation safety systems
• Early symptom management
• Multidisciplinary coordination
• Emergency access
• Respectful communication
• Patient-reported outcome monitoring
• Equitable access
• Transparent quality improvement

Patients may ask whether a center has specialized expertise, accreditation, clinical trials, emergency services and outcome data relevant to their diagnosis.

1. What is my exact diagnosis?
2. Has the pathology been reviewed by a specialist?
3. What is the cancer’s stage, grade and risk category?
4. Has the cancer spread?
5. Do I need additional imaging or laboratory tests?
6. Do I need biomarker or molecular testing?
7. Is inherited genetic testing appropriate?
8. What is the goal of treatment?
9. Is cure a realistic goal?
10. What happens without treatment?
11. What treatment options are available?
12. Which option do you recommend and why?
13. What are the expected benefits?
14. What are the major short- and long-term risks?
15. How will treatment affect daily life?
16. Will I need more than one treatment type?
17. In what order will treatments be given?
18. Is treatment neoadjuvant, adjuvant, concurrent or maintenance?
19. Has my case been reviewed at a tumor board?
20. Would a second opinion be helpful?
21. How quickly must treatment begin?
22. Is a clinical trial appropriate now?
23. How will treatment response be measured?
24. When will scans or laboratory tests be repeated?
25. What would cause the treatment plan to change?
26. What side effects are most likely?
27. Which side effects can be prevented?
28. Which symptoms require an urgent call?
29. What is my fever-reporting threshold?
30. Whom should I contact after hours?
31. Which hospital should evaluate me in an emergency?
32. Can I continue my prescription medicines?
33. Which vitamins, herbs or supplements should I avoid?
34. Are there food interactions with my treatment?
35. Should I receive vaccines before or during treatment?
36. Could treatment affect fertility?
37. Should fertility preservation happen before treatment?
38. How could treatment affect sexual health?
39. Should I meet a dietitian?
40. Should I begin physical therapy or prehabilitation?
41. What exercise is safe?
42. Are integrative services available?
43. Which complementary therapies are safe for me?
44. Should I meet a palliative-care specialist?
45. What mental-health support is available?
46. Can a patient navigator assist me?
47. What will treatment cost?
48. Is financial counseling available?
49. How will my primary-care clinician be involved?
50. Will I receive a treatment summary and survivorship plan?
51. What is the plan if the cancer returns?
52. How will my goals and preferences be included?

Myth: Every patient with the same cancer receives the same treatment.

Fact: Stage, biomarkers, health, prior treatment and patient preferences may change the plan.

Myth: Modern treatment means using only the newest medicine.

Fact: Established surgery, radiation, chemotherapy and hormone therapy remain highly effective for many cancers.

Myth: More treatment is always better.

Fact: Treatment should provide meaningful benefit that justifies its risks and burden.

Myth: Precision medicine guarantees a matching drug.

Fact: Testing may find no actionable biomarker, and a matched treatment may not work.

Myth: Palliative care means treatment has stopped.

Fact: Palliative care can begin at diagnosis and continue with active cancer treatment.

Myth: Supportive care is optional comfort care.

Fact: Symptom control, nutrition, infection prevention and rehabilitation can be essential to safe treatment.

Myth: Integrative medicine replaces oncology treatment.

Fact: Integrative care combines selected complementary approaches with standard treatment.

Myth: A dose reduction means treatment has failed.

Fact: Dose adjustments may reduce harm while preserving treatment benefit.

Myth: Feeling better proves the cancer is shrinking.

Fact: Symptoms and cancer response are related but separate outcomes.

Myth: Cancer follow-up ends after treatment.

Fact: Survivorship care monitors recurrence, late effects and overall health.

Myth: Clinical trials are used only when nothing else remains.

Fact: Trials may be available at diagnosis, during standard treatment or at recurrence.

Myth: Positive thinking determines whether treatment works.

Fact: Emotional support matters, but patients do not cause or cure cancer through attitude alone.

• □ My diagnosis has been clearly confirmed.
• □ I have a copy of my pathology report.
• □ I understand my stage, grade and risk category.
• □ Appropriate biomarker testing was considered.
• □ Inherited genetic testing was considered when relevant.
• □ The goal of treatment is clear.
• □ I understand the recommended treatments and sequence.
• □ I understand the expected benefits and major risks.
• □ My values and priorities were included.
• □ A second opinion was considered.
• □ Clinical-trial options were discussed.
• □ I have an updated medication and supplement list.
• □ I know which symptoms require urgent attention.
• □ I have daytime and after-hours contact numbers.
• □ Supportive and palliative-care needs were assessed.
• □ Nutrition, exercise and rehabilitation were addressed.
• □ Fertility and sexual-health concerns were discussed.
• □ Mental-health and caregiver support are available.
• □ Financial and transportation barriers were reviewed.
• □ A patient navigator is involved when needed.
• □ Treatment response and toxicity monitoring are scheduled.
• □ I understand the plan if treatment stops working.
• □ Follow-up and survivorship planning have begun.
• □ Complementary therapies are coordinated with the oncology team.
• □ Unproven alternatives are not replacing effective care.

• National Cancer Institute — Types of Cancer Treatment
• National Cancer Institute — Cancer Types and Treatment Information
• National Cancer Institute — Cancer Diagnosis and Staging
• National Cancer Institute — Biomarker Testing
• National Cancer Institute — Cancer Genetics
• National Cancer Institute — Cancer Surgery
• National Cancer Institute — Chemotherapy
• National Cancer Institute — Radiation Therapy
• National Cancer Institute — Immunotherapy
• National Cancer Institute — Targeted Therapy
• National Cancer Institute — Hormone Therapy
• National Cancer Institute — Stem Cell Transplant
• National Cancer Institute — Cancer Treatment Side Effects
• National Cancer Institute — Palliative Care
• National Cancer Institute — Cancer Survivorship
• National Cancer Institute — Follow-Up Medical Care
• NCCIH — Cancer and Complementary Health Approaches
• U.S. Food and Drug Administration — Oncology Center of Excellence
• U.S. Food and Drug Administration — Companion Diagnostic Devices
• National Cancer Institute — Find an NCI-Designated Cancer Center
• National Cancer Institute — Cancer Information Service
• President’s Cancer Panel — Patient Navigation and Cancer-Care Equity
• American Cancer Society — Making Cancer Treatment Decisions
• American Cancer Society — Cancer Survivorship
• National Cancer Institute — Find Cancer Clinical Trials

Modern cancer management is a coordinated process—not a single treatment. It combines accurate diagnosis, staging, molecular information, multidisciplinary expertise, cancer-directed treatment, supportive care, rehabilitation, monitoring and long-term follow-up.

Standard treatments are selected to cure cancer, reduce recurrence risk, control disease or relieve symptoms. Many patients benefit from carefully planned combinations of surgery, radiation and systemic therapy.

Supportive, palliative and integrative approaches strengthen modern cancer care by managing symptoms, preserving function and addressing emotional, social, cultural and spiritual needs. They should be coordinated with—not substituted for—effective oncology treatment.

The best plan is scientifically sound, medically safe and personally meaningful. It should reflect both the biology of the cancer and the goals of the person receiving care.

Patients and families deserve clear information, realistic expectations, shared decisions, access to second opinions, protection from misinformation and coordinated support throughout the cancer journey.